Survivors of Myocardial Infarction with Cardiogenic Shock: Long Term Outcomes.

Título original: Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock Findings From the NCDR. Referencia: Rashmee U. Shah et al. J Am Coll Cardiol. 2016;67(7):739-747.

 

Even though mortality after cardiogenic shock MI is quite high, many survive and are discharged. So far, there is little we know about their prognosis after discharge.

This study sought to assess patients undergoing acute myocardial infarction included in the ACTION registry (Acute Coronary Treatment and Intervention Outcomes Network Registry–Get with the Guidelines) post discharge. The study used proportional hazard models to test the association between cardiogenic shock and events after discharge.

Out of 112668 AMI survivors discharged, 5% presented cardiogenic shock.

Death rate was significantly higher in those presenting cardiogenic shock both at 60 days (9.6% vs. 5.5%) and one year (22.4% vs. 16.7%).

After adjusting baseline characteristics, death risk continued to be higher in those presenting cardiogenic shock within 60 days (HR: 1.62; CI 95% 1.46 to 1.80) but resulted similar after this period (HR: 1.08 between day 61 and 365; CI 95% 1.00 to 1.18).

All cause rehospitalization or death rates also resulted higher in cardiogenic shock patients at 60 days (HR: 1.28; 95% CI: 1.21 to 1.35) and after this period the risk matched non cardiogenic shock patients (HR: 0.95 between day 61 and 365; CI 95% 0.89 to 1.01).

Conclusion
For cardiogenic shock survivors, death and or rehospitalization rates are time dependent and concentrates in the first 60 days after discharge. After this period, prognosis resulted similar to that of patients with no cardiogenic shock.

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...